Ask Warren

SeouLin Bioscience

038070 · KOSDAQ · ₩038070 · 서린바이오

₩3,625▲ ₩30 (0.83%)End-of-day · Oct 27, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩21B₩20B₩20B₩23B₩16B₩18B₩20B₩17B
Cost of sales₩17B₩15B₩15B₩18B₩13B₩13B₩14B₩13B
Gross profit₩3.6B₩4.5B₩4.6B₩5.1B₩3.1B₩4.5B₩5.2B₩4B
Operating income−₩597M₩175M₩142M₩785M−₩332M₩97M−₩196M₩152M
Net income₩191M₩151M−₩182M₩823M−₩358M₩291M₩2.9B−₩419M
Net income to shareholders₩342M₩163M−₩356M₩767M−₩56M₩377M₩2.7B−₩1.2B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩115B₩119B₩119B₩114B₩113B₩102B₩102B₩98B
Current assets₩68B₩73B₩72B₩65B₩65B₩59B₩60B₩57B
Cash and equivalents₩9.3B₩11B₩10B₩8.7B₩7.2B₩8.2B₩8.9B₩8.1B
Total liabilities₩30B₩34B₩33B₩27B₩28B₩15B₩15B₩13B
Current liabilities₩25B₩33B₩32B₩25B₩26B₩14B₩14B₩11B
Borrowings₩13B₩12B₩11B₩9.1B₩8.9B₩450M₩3.5B₩1.5B
Total equity₩86B₩85B₩86B₩86B₩86B₩86B₩87B₩85B
Shareholders' equity₩84B₩84B₩84B₩84B₩84B₩83B₩84B₩84B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations−₩2.8B−₩337M₩632M₩2.8B−₩1.7B₩3.1B−₩3.4B−₩542M
Free cash flow−₩2.8B−₩337M₩632M₩2.8B−₩1.7B₩3.1B−₩3.4B−₩542M
Dividends paid₩1.7B−₩863M₩0₩0₩1.7B−₩844M₩0₩0

Consolidated where available. Amounts in won.

Also known as: SeouLin Bioscience / 서린바이오 / 038070 / KRX:038070

Source: KRX statistical information